Nirmatrelvir-Ritonavir Does Not Speed Up Alleviation of COVID-19 Symptoms

FRIDAY, April 5, 2024-- For patients with confirmed COVID-19, nirmatrelvir-ritonavir is not associated with a shorter time to sustained alleviation of symptoms than placebo, according to a study published in the April 4 issue of the New England...